Panalgo
Panalgo provides a cloud-based healthcare analytics platform (Instant Health Data) that lets life sciences organizations generate real-world evidence from claims, EHR, lab, and registry data without complex programming, serving pharmaceutical manufacturers, biotechs, research organizations, and regulators.
- Company typePrivate
- Founded1996
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Panalgo does
Panalgo provides a cloud-based healthcare analytics platform built on Amazon Web Services, anchored by its flagship Instant Health Data (IHD) platform that enables life sciences organizations to generate real-world evidence from claims, electronic medical records, laboratory, and registry datasets without complex programming. The platform is augmented by specialized modules including IHD Cloud (cloud-native deployment), IHD Data Science Module (machine learning and predictive modeling), Model Studio (custom analytical model building), Ella AI (generative AI assistant for natural-language cohort creation), LinQ Notes (NLP search across unstructured clinical data), LinQ Cohort, and Patient Access Analytics (combined with MMIT market access data). Underpinning the platform is NorstellaLinQ, a proprietary real-world data asset with 74+ billion linked, tokenized data points spanning structured and unstructured EMR, laboratory, claims, and social determinants of health. The company serves pharmaceutical manufacturers, biotech firms, research organizations, commercial and market access teams, HEOR/RWE teams, medical affairs, and pharmacovigilance groups; the European Medicines Agency is a named customer. Panalgo sells primarily through enterprise SaaS subscriptions with quote-based annual pricing, supplemented by expert Evidence Generation Services and Training & Support. The company is headquartered in Boston with a European office in Amsterdam, and has operated as a brand within the Norstella conglomerate (formed May 2022 from the combination of Evaluate, MMIT, Panalgo, and The Dedham Group) following its acquisition by MMIT in September 2021.
Panalgo firmographics
Firmographics- Name
- Panalgo
- Legal name
- Caerus US 1, Inc.
- Website
- https://panalgo.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Panalgo provides a cloud-based healthcare analytics platform (Instant Health Data) that lets life sciences organizations generate real-world evidence from claims, EHR, lab, and registry data without complex programming, serving pharmaceutical manufacturers, biotechs, research organizations, and regulators.
- Ownership category
- akta.pro rank
Panalgo industry classification
Industry- Product category
- Healthcare Analytics Software
- NAICS
- Software Publishers (5132), Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industries
- De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Data, Analytics & AI Consulting (BPAHAEAF), Data Monetization & Data Products Services (BPAEAHAL)
Keywords
Where Panalgo is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Panalgo business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Software-as-a-service subscription model providing access to the IHD analytics platform. Pricing based on enterprise agreements with unlimited user access options available.
- Analytics and Evidence Generation Services: Expert consulting services for evidence generation, HEOR studies, and custom analytics engagements alongside software deployment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS platform with custom pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Panalgo product offering
Product offeringCore offering
Panalgo develops and sells the Instant Health Data (IHD) analytics platform, a cloud-based software solution that allows life sciences organizations to analyze healthcare data without complex programming. The platform ingests claims, electronic medical records, laboratory, registry, and integrated real-world data sources, and is augmented by AI-powered tools (Ella AI, LinQ Notes), cloud deployment (IHD Cloud), and an integrated real-world data asset (NorstellaLinQ). Revenue is generated primarily through enterprise SaaS subscriptions and complementary evidence generation and analytics services.
Product overview
Panalgo offers a platform-plus-modules architecture centered on the Instant Health Data (IHD) analytics platform. IHD serves as the core powerhouse for real-world evidence generation, supporting rapid analysis of claims, EHR, lab, registry, and integrated datasets. The platform is augmented by specialized modules including IHD Cloud (cloud-native AWS deployment), IHD Data Science Module (machine learning/predictive analytics), Model Studio (custom model building), Ella AI (generative AI assistant for natural language cohort creation), LinQ Notes (unstructured data exploration), LinQ Cohort (cohort definition), and Patient Access Analytics (market access insights). The NorstellaLinQ Real-World Data asset—74+ billion linked data points—underpins these capabilities. The ecosystem is completed by expert Evidence Generation Services and a Partner Network. This integrated approach enables HEOR, epidemiology, regulatory, and commercial teams to generate insights without complex programming.
Differentiator
Problem solved
Functional benefit
Products and services
- Instant Health Data (IHD) Analytics Platform Flagship cloud-based healthcare analytics platform that eliminates complex programming, enabling life sciences teams to generate real-world evidence from claims, EHR, lab, and registry data in minutes rather than weeks.
- IHD Cloud Cloud-native deployment of the IHD platform within the client's AWS environment, featuring orchestration layer for optimized resource allocation, fault-tolerant architecture, advanced telemetry, and unlimited enterprise-wide user access.
- Model Studio Tool for building and deploying custom analytical models on the IHD platform.
- Ella AI Generative AI-powered assistant enabling life sciences teams to build research-ready cohorts, generate insights, and make decisions using natural language queries without SQL or coding, built on the NorstellaLinQ data asset.
- LinQ Notes Exploratory data tool enabling natural language search across unstructured clinical data including physician notes, imaging reports, dictations, and discharge summaries, requiring no NLP experience.
- LinQ Cohort Module for patient cohort definition and analysis within the IHD platform ecosystem.
- NorstellaLinQ Real-World Data Biopharma's first fully integrated data asset with over 74 billion linked, tokenized data points spanning structured EMR, laboratory, claims, and social determinants of health data; powers products and solutions across Norstella brands.
- Patient Access Analytics Solution combining the IHD platform with MMIT market access data for instant analysis of patient access barriers, coverage decisions, and prescribing patterns.
- Evidence Generation Services Expert analytics and evidence generation consulting services supporting HEOR, epidemiology, regulatory, and commercial teams in generating real-world evidence and custom analytics engagements alongside software deployment.
- Training & Support Training and support services for IHD platform users to enable adoption and effective use of the analytics platform.
Quantifiable outcome
- Complex analyses that would take weeks or months can be completed in days or hours
- +3 more outcomes
Companies that use Panalgo
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
Panalgo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature7 records
Panalgo partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered strategic and core.
- NavidencestrategicStrategic partnership embeds Navidence's validated patient phenotype definitions directly into Panalgo's workflow for faster insights and more accurate patient identification.
- Atropos Evidence NetworkstrategicNorstellaLinQ dataset achieved top decile scores on Atropos Real World Fitness Score and added to Atropos Evidence Network for data quality recognition.
- NorstellaLinQcoreNorstellaLinQ is the biopharma industry's first fully integrated data asset built on 74+ billion linked data points. Powers Panalgo's AI tools including Ella AI and provides unified data access across all Norstella brands.
- COTAstrategicPartnership adds oncology data from COTA to Panalgo's IHD platform, enhancing real-world data capabilities for cancer research and treatment analysis.
- Amazon Web Services (AWS)coreAWS powers IHD Cloud deployment, providing scalable and flexible cloud infrastructure. AWS re:Invent participation planned for 2024. Platform available in AWS Marketplace for seamless enterprise procurement.
- NorstellacoreNorstella is the parent company formed by combining Evaluate, MMIT, Panalgo, and The Dedham Group. Panalgo operates as a brand within the Norstella family united around the mission of helping patients gain access to life-saving therapies. Norstella provides Panalgo access to combined brand assets, cross-selling opportunities, and shared innovation infrastructure.
- MMITcoreMMIT acquired Panalgo in September 2021, leading to combined Patient Access Analytics solution leveraging both MMIT's market access data and Panalgo's IHD platform.
- Premier Inc.strategicPartnership made Premier Healthcare Database available through IHD platform, enabling researchers to access gold-standard hospital data without custom programming. Premier Applied Sciences division collaborated on integration.
- Atropos HealthstrategicPartner Network member providing access to additional real-world evidence capabilities and data sources within the Norstella ecosystem.
Scale indicators6 records
Recent moves10 records
Expansion highlights6 records
Panalgo competitors and assessment
Company assessmentDirect peers
- Veradigm (formerly Allscripts): Veradigm operates one of the largest ambulatory EHR-derived real-world data assets (Veradigm Network) used for life sciences research, clinical trials, and RWE. It competes with Panalgo by offering vertically integrated EHR data plus analytics for pharma.
- Atropos Health: Atropos Health operates a real-world evidence generation platform backed by an Evidence Network that scores data fitness for specific research questions. It is a Panalgo/Norstella Partner Network member while also being a peer for rapid RWE generation against de-identified patient data.
- TriNetX: TriNetX operates a global real-world data and analytics network for clinical research, enabling cohort feasibility, protocol design, and RWE generation for pharma sponsors. It competes head-on with IHD in serving biopharma RWE teams and is also a Partner Network ally of Panalgo's parent Norstella.
- Datavant: Datavant provides healthcare data connectivity, de-identification, and tokenization technology that links disparate patient datasets for life sciences RWE. Its data-linking layer is complementary to and competitive with NorstellaLinQ's 74B+ linked, tokenized data points.
- Flatiron Health: Flatiron Health provides real-world oncology data and evidence generation used by life sciences companies and academic researchers, now part of Roche. It competes directly with Panalgo's oncology RWE capabilities, particularly via the COTA partnership.
- Aetion: Aetion provides a science-driven RWE analytics platform used by biopharma, payers, and regulators (including FDA collaborations) for regulatory-grade real-world evidence generation. It directly competes with IHD on regulatory-grade HEOR and safety/efficacy analytics.
- ConcertAI: ConcertAI is an oncology-focused real-world data and AI analytics platform serving biopharma with patient-level EHR-derived data, evidence generation, and clinical trial solutions. It directly competes with Panalgo's IHD and NorstellaLinQ for oncology RWE workloads (and has hired talent from the same talent pool).
Broad incumbents
- IQVIA: IQVIA is the largest life sciences technology and analytics provider, operating a broad real-world evidence and clinical analytics platform that directly overlaps with Panalgo's IHD capabilities for HEOR, RWE, and commercial analytics. It is the most comprehensive incumbent competing for the same pharma wallet.
- Veeva Systems: Veeva provides the dominant life sciences CRM, regulatory, and clinical data cloud used by most top-20 pharma. While not a direct RWE analytics competitor, it is a broad incumbent sitting in the same buyer accounts and increasingly expanding into data and analytics adjacencies.
- Palantir Technologies: Palantir Foundry is increasingly adopted by large pharma for clinical, commercial, and RWE data integration and AI analytics. It represents a broad incumbent threat that can absorb mid-tier RWE analytics workloads with deeper enterprise platform economics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Panalgo social profiles
Digital presencePanalgo compliance and trust
Trust signalCompliance1 record
Panalgo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Panalgo leadership team
Management profileNumber of profiles
Profiles10 records
Panalgo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Panalgo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Panalgo
What does Panalgo do?
Panalgo develops and sells the Instant Health Data (IHD) analytics platform, a cloud-based software solution that allows life sciences organizations to analyze healthcare data without complex programming. The platform ingests claims, electronic medical records, laboratory, registry, and integrated real-world data sources, and is augmented by AI-powered tools (Ella AI, LinQ Notes), cloud deployment (IHD Cloud), and an integrated real-world data asset (NorstellaLinQ). Revenue is generated primarily through enterprise SaaS subscriptions and complementary evidence generation and analytics services.
Is Panalgo a public or private company?
Panalgo is a private company. It is classified as corporate owned and is currently operating.
When was Panalgo founded?
Panalgo was founded in 1996. It employs 51 to 100 people.
Where is Panalgo based?
Panalgo is headquartered in Boston, United States, in the North America region.
How does Panalgo make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are analytics and Evidence Generation Services.
Who are Panalgo's main competitors?
Direct peers on record are Veradigm (formerly Allscripts), Atropos Health, TriNetX, Datavant, Flatiron Health, Aetion and ConcertAI. Broad incumbents are IQVIA, Veeva Systems and Palantir Technologies.
Does Panalgo have an API?
No public API is recorded for Panalgo.
What industry is Panalgo in?
Panalgo's product category is Healthcare Analytics Software. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLACAIAK, De-identification, Tokenization & Privacy-Preserving Data Platforms. Its NAICS code is 5132 and its SIC code is 7372.